恒锋信息科技股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日和 2025 年 5 月 29 日先后召开第四届董事会第十次会议和 2024 年年度股东大会，审议通过 了《关于变更公司注册资本及修订公司章程的议案》，同意对公司注册资本进行变更 及修订《公司章程》部分条款。具体内容详见公司于 2025 年 4 月 28 日在巨潮资讯 网（http://www.cninfo.com.cn）上披露的《关于变更公司注册资本及修订公司章程 的公告》（公告编号：2025-025）。 近日，公司完成了注册资本变更登记及《公司章程》的备案手续，并取得福州市 市场监督管理局换发的《营业执照》，具体情况如下： 1、统一社会信用代码：9135010026017703XW 2、名称：恒锋信息科技股份有限公司 3、类型：股份有限公司（上市） 4、住所：福州市鼓楼区软件大道 89 号福州软件园 F 区 8 号楼 4 层 437 室 | 证券代码：300605 | 证券简称：恒锋信息 | 公告编号：2025-037 | | --- | --- | --- | | 债券代码：123173 | 债券简称：恒锋转债 | | 恒锋信 ...

| 证券代码：300605 | 证券简称：恒锋信息 | 公告编号：2025-036 | | --- | --- | --- | | 债券代码：123173 | 债券简称：恒锋转债 | | 恒锋信息科技股份有限公司 公司于近日收到罗文文先生出具的《减持公司股份计划告知函》，现将有关 情况公告如下： 关于部分董事减持公司股份的预披露公告 公司董事罗文文先生保证向公司提供的信息内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、股东的基本情况 截至本公告披露日，公司董事罗文文先生共持有公司股份 357,376 股，占 公司总股本比例 0.2171%。 | | | | | | 计划减持 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 减持 | 减持股份来源 | 拟减持股 | | 数量占本 | | 减持 | 减持期间 | 减持 | | 名称 | 原因 | | 份数量 | | 公司总股 | | 方式 | | 价格 | | | | | | | 本的比例 | | | | | | 罗文文 | 个 人 资 ...

Core Viewpoint - The ophthalmology medical concept sector has shown a positive performance, with a 1.30% increase, ranking fifth among concept sectors, driven by significant gains in several stocks [1][2]. Group 1: Sector Performance - The ophthalmology medical concept sector saw 28 stocks rise, with notable performers including Innovation Medical, *ST Jingfeng, and others reaching their daily limit up [1]. - Key gainers in the sector included Innovation Medical (+14.87%), Guanhao Biological (+8.88%), and Kanghong Pharmaceutical (+7.84%) [1]. - Conversely, the sector also experienced declines, with major losers being Skyworth Digital (-3.19%), Jincheng Pharmaceutical (-2.40%), and Doctor Eye Glasses (-2.10%) [1]. Group 2: Capital Flow - The ophthalmology medical concept sector attracted a net inflow of 208 million yuan, with 23 stocks receiving net inflows, and 8 stocks exceeding 10 million yuan in net inflow [2]. - The leading stock in terms of net capital inflow was Innovation Medical, which saw a net inflow of 378 million yuan, followed by Kanghong Pharmaceutical and Hengfeng Information with net inflows of 66.97 million yuan and 46.49 million yuan, respectively [2][3]. - The net inflow ratios for top stocks included Innovation Medical (26.37%), *ST Jingfeng (17.55%), and Hengfeng Information (13.55%) [3].

福建天衡联合（福州）律师事务所 福建天衡联合（福州）律师事务所 关于恒锋信息科技股份有限公司 2024 年年度股东会的 关于恒锋信息科技股份有限公司 法律意见书 法律意见书 律师声明事项 本所及本所律师依据《中华人民共和国证券法》《律师事务所从事证券法律业 务管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及本法律意 见书出具日以前已经发生或者存在的事实，严格履行了法定职责，遵循了勤勉尽责 和诚实信用原则，进行了充分的核查验证，保证本法律意见书所认定的事实真实、 准确、完整，所发表的结论性意见合法、准确，不存在虚假记载、误导性陈述或者 重大遗漏，并承担相应法律责任。 2024 年年度股东会的 法律意见书 〔2023〕天衡福顾字第 0009-09 号 致：恒锋信息科技股份有限公司 引 言 福建天衡联合（福州）律师事务所接受恒锋信息科技股份有限公司（以下简称 "公司"）的委托，指派本所律师参加公司 2024 年年度股东会（以下简称"本次会 议"），并根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司 股东大会规则》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公 司股东大会网络投 ...

| 证券代码：300605 | 证券简称：恒锋信息 | 公告编号：2025-035 | | --- | --- | --- | | 债券代码：123173 | 债券简称：恒锋转债 | | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 恒锋信息科技股份有限公司 2024 年年度股东大会决议公告 1、本次股东大会未出现否决议案的情形； 2、本次股东大会不涉及变更以往股东大会已通过决议的情形。 一、 会议召开和出席情况 (一)会议召开情况 1、会议召集人：公司董事会 3、现场会议召开地点：福建省福州市闽侯县上街镇乌龙江中大道科技东路创新 园5号楼公司会议室 4、股权登记日：2025年5月22日（星期四） 5、会议召开方式： 现场投票和网络投票相结合的方式。股东大会股权登记日在册的公司股东有权 选择现场投票、网络投票中的一种方式行使表决权，如果同一表决权出现重复投票 1 表决的，以第一次有效投票表决结果为准； 2、会议召开时间： （1）现场会议时间：2025年5月29日（星期四）下午14：00； （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票 ...

Core Viewpoint - The increase in terminated agreements for equity transfers in the A-share market is attributed to stricter regulatory scrutiny and market volatility affecting the parties involved [1][2][4]. Group 1: Termination of Agreements - As of May 26, 2023, 25 companies have announced the termination of equity transfer agreements this year, matching the total for the entire previous year [1][2]. - In May alone, 13 companies announced the termination of agreements, with 10 involving controlling shareholders or actual controllers [1][2]. - The majority of these terminated agreements were signed after the implementation of the new reduction regulations in May 2022, with 80% occurring in the fourth quarter of last year [2][3]. Group 2: Reasons for Termination - The reasons for the termination of agreements include stricter regulatory oversight, insufficient funds from the transferee, and fluctuations in secondary market prices leading to breaches of contract [1][2][5]. - Many of the terminated agreements had not received confirmation from the exchange and had not completed the necessary transfer registration procedures [2][3]. Group 3: Regulatory Challenges - The difficulty in regulatory oversight stems from the opaque nature of funding sources, as private equity funds and trust plans do not disclose ultimate investors, complicating the verification process [5][6]. - Key regulatory challenges include identifying hidden relationships between transferors and transferees, and the difficulty in detecting off-the-books agreements that circumvent regulations [5][6]. Group 4: Recommendations for Strengthening Regulation - Suggestions for enhancing regulatory oversight include requiring private equity funds to disclose ultimate beneficiaries, establishing dynamic monitoring of transfer agreements, and increasing penalties for violations [6]. - The use of technology, such as AI, to create a database of equity relationships and identify unusual networks among transferees is also recommended [6].

【要闻报道】 英伟达拟再推"中国特供"芯片 据参考消息援引新加坡《联合早报》网站5月25日引述路透社消息报道，美国芯片巨头英伟达据报将为 中国市场推出一款基于Blackwell架构的人工智能（AI）芯片，售价将大幅低于先前的H20芯片，预计最 快于6月开始量产。 报道称，这款采用最新一代Blackwell架构的AI处理器，预计售价介于6500美元至8000美元之间，明显 低于H20的定价。较低的售价通常意味着芯片规格相对较弱，制造工艺也更为简化。 点评：这将是英伟达第三次为中国市场推出符合美国监管要求的降级版芯片。美国政府日前禁止英伟达 向中国销售基于Hopper架构的H20芯片。 特朗普威胁50%关税两天后改口：恢复与欧盟贸易谈判窗口期 美国总统特朗普在与欧盟委员会主席冯德莱恩通电话后表示，他将把欧盟面临50%关税的最后期限延长 至7月9日。 特朗普当地时间周日在返回华盛顿的途中对记者说："我们进行了一次非常愉快的通话，我同意将它撤 回。" 冯德莱恩稍早前在X上发文称，"欧洲已准备好迅速、果断地推进谈判"，但"达成一项好的协议需要时 间，直到7月9日"。那是特朗普暂停所谓对等关税90天的截止日。 点评：这次 ...

Core Viewpoint - The recent increase in terminated share transfer agreements among listed companies highlights a dual nature in the market, where some companies continue to pursue strategic investments while others face regulatory scrutiny and market conditions that hinder transactions [2][5][6]. Group 1: Market Dynamics - In May, 13 listed companies announced the termination of share transfer agreements, a significant increase compared to previous months, which typically saw only three to five cases [5]. - The reasons for termination often include incomplete procedures and market conditions where previously set transfer prices are now below current market values [5][6]. - Despite the rise in terminations, there are still ongoing agreements aimed at introducing strategic investors or changing actual controllers, indicating that the market remains active [7][8]. Group 2: Regulatory Environment - The tightening of regulations following the introduction of new reduction rules has led to increased scrutiny of share transfer agreements, with calls for clearer prohibitions on certain behaviors to prevent gray operations [3][9]. - The market is seeing a trend where parties involved in agreements are extending lock-up periods to enhance compliance and reduce the risk of speculative trading [10][11]. Group 3: Strategic Implications - Protocol transfers serve as an effective tool for major shareholders to meet liquidity needs while avoiding direct impacts on stock prices from secondary market sales [6][8]. - The presence of financial investors as transferees is becoming more challenging, but agreements aimed at strategic partnerships continue to progress normally [8]. - The market's dual characteristics suggest a need for balance between resource allocation functions and risk prevention in the context of share transfers [3][10].

Group 1 - Ningde Times participated in the completion of the Zeyuan Fund, with a total scale of 10.128 billion yuan, increasing by 50.42% from the previous announcement [3] - Zhongjin Gold's controlling shareholder plans to inject four companies into the company to resolve competition issues, including acquiring stakes in Inner Mongolia Jintao and others [4][5] - Keli Yuan plans to invest an additional 500 million yuan in a storage industry fund, increasing its total investment to 700 million yuan [6] Group 2 - China Shenhua intends to acquire 7.43% of the National Energy Group Financial Company for 2.929 billion yuan, which is expected to increase its net profit by 97 million yuan [7] - Weir Shares plans to issue H-shares and list on the Hong Kong Stock Exchange [8] - Hualan Shares is establishing a joint venture for Tibetan medicinal baths and plaster products, with a registered capital of 7 million yuan [15] Group 3 - Yunnan Copper plans to acquire 40% of Liangshan Mining through a share issuance, with the stock resuming trading on May 26 [10] - Ruishun Technology's subsidiary plans to establish a joint venture in Malaysia to provide automation solutions [11] - ST Quanwei's stock will be subject to additional risk warnings due to ongoing litigation involving a subsidiary [12] Group 4 - Hengfeng Information's controlling shareholder has terminated the agreement to transfer part of the company's shares, with no impact on control [13] - Huadian Technology's subsidiary has not yet commenced substantial construction on a polyurethane new materials project [14] - ST Yinjian will remove the delisting risk warning and some other risk warnings, changing its stock name [38] Group 5 - China Tonghao won approximately 3.789 billion yuan in contracts in the rail transit market from March to April [39] - Intercontinental Oil and Gas plans to invest about 848 million USD in the Iraq South Basra project [40][41] - Jiaying Pharmaceutical's subsidiary signed a contract for the development of a traditional Chinese medicine innovation project [42] Group 6 - Ruidong Intelligent signed a strategic cooperation agreement with Shunde Vocational and Technical College to enhance collaboration in technology [43] - Jiaojian Co. won a bid for a drainage project worth 225 million yuan [44] - Hengshun Vinegar's controlling shareholder plans to increase its stake in the company by 50 to 100 million yuan [45]

Core Viewpoint - The company announced the termination of a previously signed share transfer agreement between its controlling shareholders and a third party, which will not affect the company's control or governance structure [1] Group 1 - The controlling shareholders, Wei Xiaoxi and Ou Linjie, have returned the first installment of the share transfer payment to Cheng Wenhong [1] - The termination of the agreement means that all parties involved will not bear any liability for breach of contract [1] - The termination will not lead to any changes in the company's control or impact its operational governance [1]